tiprankstipranks

Casi Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright

H.C. Wainwright analyst Sean Lee lowered the firm’s price target on Casi Pharmaceuticals (CASI) to $4 from $6 and keeps a Buy rating on the shares. The firm expects the divestment of the company’s Chinese business to occur before the end of Q3.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue